Organization | MinaPharm Pharmaceuticals

MinaPharm Pharmaceuticals Report issue

For profit Phase 1 Phase 4

Founded: Cairo Egypt (1958)

Status: No NME R&D (1958)

Organization Overview

First Clinical Trial

2012

NCT01649245

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

MinaPharm Pharmaceuticals

Active Ingredients

Drugs in Phase 4 Trials (7)

alfacalcidol (1 trial)

follitropin alfa (1 trial)

hirudin (1 trial)

interferon alpha-2a (roferon-a) (2 trials)

interferon alpha-2b (Intron-A) (1 trial)

nitazoxanide (alinia) (1 trial)

ribavirin (virazole) (1 trial)

Drugs in Phase 1 Trials (2)

ledipasvir (Harvoni) (1 trial)

sofosbuvir (sovaldi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hematoma (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 9